Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Solid Biosciences Inc. - Common Stock (NQ:SLDB)

7.490 +0.110 (+1.49%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 808,144
Open 7.120
Bid (Size) 7.470 (2,400)
Ask (Size) 7.480 (700)
Prev. Close 7.380
Today's Range 7.010 - 7.815
52wk Range 2.410 - 8.720
Shares Outstanding 19,601,539
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an... 
Via MarketMinute
News headline image
Xpeng, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga

Performance

YTD
+37.4%
+37.4%
1 Month
+20.8%
+20.8%
3 Month
+32.8%
+32.8%
6 Month
+27.6%
+27.6%
1 Year
+117.4%
+117.4%

More News

Read More
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Fed Trims Rates by 0.25%: A New Era of Dovish Policy and Portfolio Rebalancing
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Federal Reserve Poised for September Rate Cut Amidst High Market Expectations and Powell's Jackson Hole Address
Via MarketMinute
Topics Bonds Credit Cards Economy
News headline image
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside ↗
Via MarketBeat
Topics Death
News headline image
Solid Biosciences Stock Pops On US, Canada Nod For Gene Therapy Trials: Retail Buzz Spikes ↗
Via Stocktwits
News headline image
Analyst Downgrades Sarepta As Elevidys Safety Clouds Future Demand ↗
Via Benzinga
News headline image
Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
Via MarketBeat
Topics Earnings
News headline image
Sarepta Therapeutics, KULR Technology Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Incyte Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗
Via Benzinga
News headline image
Can Solid Biosciences Challenge Sarepta in the DMD Market?
Via MarketBeat
News headline image
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors
From Climb Bio, Inc.
Via GlobeNewswire
News headline image
Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week ↗
Via Stocktwits
News headline image
Solid Biosciences Soars 32% on Trial Data: 189% Upside from Here?
Via MarketBeat
News headline image
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move? ↗
Via Stocktwits
News headline image
Solid Biosciences Stock Surges On Upbeat Duchenne Muscular Dystrophy Gene Therapy Data ↗
Via Benzinga
News headline image
Stocks Quiet As S&P 500 Nears All-Time High ↗
Via Talk Markets
Topics Stocks Stocks / Equities
News headline image
Tuesday's session: gap up and gap down stocks ↗
Via Chartmill
News headline image
Wondering what's happening in today's pre-market session? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development ↗
Via Benzinga

Frequently Asked Questions

Is Solid Biosciences Inc. - Common Stock publicly traded?
Yes, Solid Biosciences Inc. - Common Stock is publicly traded.
What exchange does Solid Biosciences Inc. - Common Stock trade on?
Solid Biosciences Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Solid Biosciences Inc. - Common Stock?
The ticker symbol for Solid Biosciences Inc. - Common Stock is SLDB on the Nasdaq Stock Market
What is the current price of Solid Biosciences Inc. - Common Stock?
The current price of Solid Biosciences Inc. - Common Stock is 7.490
When was Solid Biosciences Inc. - Common Stock last traded?
The last trade of Solid Biosciences Inc. - Common Stock was at 04/02/26 04:00 PM ET
What is the market capitalization of Solid Biosciences Inc. - Common Stock?
The market capitalization of Solid Biosciences Inc. - Common Stock is 146.82M
How many shares of Solid Biosciences Inc. - Common Stock are outstanding?
Solid Biosciences Inc. - Common Stock has 147M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.